相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease Open-Label Extension of a Phase 3 Randomized Controlled Trial
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
Lili Zhu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review
Miriana d'Alessandro et al.
LIFE-BASEL (2022)
Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease
Seung Min Jung et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis
Shaohua Wang et al.
FASEB JOURNAL (2022)
Biomarkers of connective tissue disease-associated interstitial lung disease in bronchoalveolar lavage fluid: A label-free mass spectrometry-based relative quantification study
Jing Ye et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study
Patrycja Rzepka-Wrona et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-a signalling pathways
Wen Zhu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level
Danfeng Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Interstitial lung diseases
Marlies Wijsenbeek et al.
LANCET (2022)
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data
Elisa Fiorentini et al.
LIFE-BASEL (2022)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Alice Cole et al.
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY (2022)
The prevalence and burden of interstitial lung diseases in the USA
Niranjan Jeganathan et al.
ERJ OPEN RESEARCH (2022)
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
Changfu Yao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease
Yunqi Bao et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Kevin Shenderov et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF
Francesco Bonella et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Fibroblasts and their responses to chronic injury in pulmonary fibrosis
B. Wu et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population
Daryle J. DePianto et al.
JCI INSIGHT (2021)
Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
Muhan Zheng et al.
RHEUMATOLOGY AND THERAPY (2021)
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
Eleanor Valenzi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Categorization of lung mesenchymal cells in development and fibrosis
Xue Liu et al.
ISCIENCE (2021)
Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis
Shuo Liu et al.
THORAX (2021)
Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese
Takuma Isshiki et al.
SCIENTIFIC REPORTS (2021)
Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
Tihong Shao et al.
FRONTIERS IN IMMUNOLOGY (2021)
The cGAS-STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Transforming growth factor-beta in tissue fibrosis
Nikolaos G. Frangogiannis
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
Muriel Elhai et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Vitamin D levels are prognostic factors for connective tissue disease associated interstitial lung disease (CTD-ILD)
Yujuan Gao et al.
AGING-US (2020)
The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
Hua Ma et al.
BMC PULMONARY MEDICINE (2020)
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Tanyalak Parimon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial
Nupoor Acharya et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases A meta-analysis
Danli Zhong et al.
MEDICINE (2020)
Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
Ludivine Renaud et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Giulia Cassone et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs
Gianni Carraro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease
Alain Lescoat et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
Taylor S. Adams et al.
SCIENCE ADVANCES (2020)
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment
Niranjan Jeganathan et al.
LUNG (2020)
Neutrophil-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease
Victoria Maria Ruta et al.
MEDICINA-LITHUANIA (2020)
The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease
Wenhan Huang et al.
RHEUMATOLOGY (2020)
The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease
Ruihua Ma et al.
FASEB JOURNAL (2020)
Contributions of alveolar epithelial cell quality control to pulmonary fibrosis
Jeremy Katzen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Spectrum of Fibrotic Lung Diseases
Marlies Wijsenbeek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Expression of the Autoantigen Topoisomerase-1 is Enriched in the Lung Tissues of Patients With Autoimmune Interstitial Lung Disease: A Case Control Study
Tricia R. Cottrell et al.
ACR OPEN RHEUMATOLOGY (2020)
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wenxia Wang et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Pathogenesis of systemic sclerosis associated interstitial lung disease
Svetlana Nihtyanova et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Increases in tumor markers are associated with primary Sjogren's syndrome-associated interstitial lung disease
Lei Shi et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis
Antje Prasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway
Guangxia Yang et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Shruthi Hamsanathan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Christina Morse et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
Olivier Bonhomme et al.
RHEUMATOLOGY (2019)
The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B
Qinghua Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
Eleanor Valenzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Marlies Wijsenbeek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Cell Death in the Lung: The ApoptosisNecroptosis Axis
Maor Sauler et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Chad A. Newton et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities
Aryeh Fischer et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
Jeong Seok Lee et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
David W. Waters et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Deletion of c-FLIP from CD11b(hi) Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
Alexandra L. McCubbrey et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Pulmonary phenotypes associated with genetic variation in telomere-related genes
Thijs W. Hoffman et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Matrix remodeling in chronic lung diseases
Bon-Hee Gu et al.
MATRIX BIOLOGY (2018)
Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease
Hiroko Numajiri et al.
JOURNAL OF DERMATOLOGY (2018)
Diverse mechanisms for endogenous regeneration and repair in mammalian organs
James M. Wells et al.
NATURE (2018)
Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease
Qian Jin et al.
ARCHIVES OF RHEUMATOLOGY (2018)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
P. -A. Juge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis
Yun Peng et al.
CLINICAL RHEUMATOLOGY (2018)
Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer et al.
NATURE COMMUNICATIONS (2017)
Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus
Jie An et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease
Chunsun Jiang et al.
AGING CELL (2017)
Genetics in idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
Amarpreet Kaur et al.
FRONTIERS IN MEDICINE (2017)
SHARED GENETIC PREDISPOSITION IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE AND FAMILIAL PULMONARY FIBROSIS
P-A. Juge et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema
Susan E. Stanley et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Adam J. Byrne et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma
Andrea Fava et al.
ARTHRITIS RESEARCH & THERAPY (2016)
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
Justin M. Oldham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Telomere Length in Interstitial Lung Diseases
Reinier Snetselaar et al.
CHEST (2015)
MUC5B and Idiopathic Pulmonary Fibrosis
Ivana V. Yang et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
YKL-40 in Pediatric Asthma, MUC5B Promoter Polymorphism in Idiopathic Pulmonary Fibrosis, and Esmolol in Septic Shock
Hrishikesh S. Kulkarni et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications
S. Zhang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Neutrophil extracellular traps promote differentiation and function of fibroblasts
Akrivi Chrysanthopoulou et al.
JOURNAL OF PATHOLOGY (2014)
Lung regeneration: mechanisms, applications and emerging stem cell populations
Darrell N. Kotton et al.
NATURE MEDICINE (2014)
Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis
Romy B. Christmann et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
Raphael Borie et al.
PLOS ONE (2013)
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth et al.
LANCET RESPIRATORY MEDICINE (2013)
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita
Blanche P. Alter et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Pulmonary fibrosis: patterns and Perpetrators
Paul W. Noble et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Vitamin D Deficiency and Reduced Lung Function in Connective Tissue-Associated Interstitial Lung Diseases
Jared T. Hagaman et al.
CHEST (2011)
The three R's of lung health and disease: repair, remodeling, and regeneration
Michael F. Beers et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma
Faye N. Hant et al.
JOURNAL OF RHEUMATOLOGY (2009)
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Jonathan K. Alder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Roles of T lymphocytes in pulmonary fibrosis
Irina G. Luzina et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression
Nicole S. L. Goh et al.
ARTHRITIS AND RHEUMATISM (2007)
Telomerase mutations in families with idiopathic pulmonary fibrosis
Mary Y. Armanios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases
H. Satoh et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT
F Kinoshita et al.
RESPIRATORY MEDICINE (2004)
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs
YP Moodley et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Interstitial lung disease in polymyositis and dermatomyositis
I Marie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis
H Takahashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Extensive surface phenotyping of alveolar macrophages in interstitial lung disease
ML Taylor et al.
CLINICAL IMMUNOLOGY (2000)